Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Dudley RA, Yazdany J.
Gianfrancesco MA, et al. Among authors: haserodt s.
Rheumatol Int. 2017 Oct;37(10):1611-1618. doi: 10.1007/s00296-017-3782-6. Epub 2017 Jul 26.
Rheumatol Int. 2017.
PMID: 28748425
Free PMC article.